Merck & Co., Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Merck & Co., Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Merck & Co., Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $656M, a 9.52% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $656M +$57M +9.52% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $599M +$312M +109% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $287M -$117M -29% Dec 31, 2021 10-K 2023-02-24
Q4 2020 $404M -$696M -63.3% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $1.1B -$248M -18.4% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $1.35B +$448M +49.8% Dec 31, 2018 10-K 2020-02-26
Q4 2017 $900M +$632M +236% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $268M -$36M -11.8% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $304M +$39M +14.7% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $265M +$60M +29.3% Dec 31, 2014 10-K 2016-02-26
Q4 2013 $205M +$98M +91.6% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $107M -$139M -56.5% Dec 31, 2012 10-K 2014-02-27
Q4 2011 $246M +$50M +25.5% Dec 31, 2011 10-K 2013-02-28
Q4 2010 $196M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.